FIELD: virology. SUBSTANCE: for preparation of AIDS vaccine, antigen that is sequence 735-752 of viral capsid protein gp 41 is injected to animal. The antibodies produced are isolated and injected to another animal from which antibody- producing splenocytes are isolated to produce hybridomas. After incubation of the hybridomas, there is obtained an anti- idiotypic antibody that is capable of attaching to CD 4-cell marker-related epitope and inhibiting the binding between CD 4 cell marker and any of indicator antibodies Leu AAA and OKT AAAA. EFFECT: increased efficacy. 14 tbl
Title |
Year |
Author |
Number |
SYNTHETIC HIV PEPTIDE (VARIANTS), IMMUNOGENIC COMPOSITION FOR INDUCTION OF IMMUNE RESPONSE AGAINST HIV PEPTIDES, DIAGNOSTIC SET FOR ASSAY OF HIV-SPECIFIC ANTIBODIES |
1994 |
- Sia Charlz D.I.
- Chong Pele
- Klejn Majkl Kh.
|
RU2201421C2 |
PEPTIDE (VARIANTS) AND METHOD OF ITS PRODUCTION, PHARMACEUTICAL AGENT, ANTIBODY AND METHOD OF ITS PRODUCTION |
1994 |
- Khermann Katinger
- Tomas Muster
|
RU2181379C2 |
SYNTHETIC PEPTIDE, SYNTHETIC LIPOPEPTIDE, IMMUNOGENIC CONJUGATE (VARIANTS), METHOD OF OLIGOMER PREPARING, POLYSACCHARIDE PROTECTED BY SOLID POLYETHYLENE GLYCOL MONOMETHYL ESTER |
1993 |
- Pele Chong
- Ali Kandil
- Charl'Z Saja
- Majkl Kh.Klejn
|
RU2141527C1 |
IMMUNOGENIC COMPOSITIONS BASED ON SYNTHETIC PEPTIDES MIMICKING ACTUAL DETERMINANTS OF HIV1 gp120 |
2014 |
- Sidorovich Igor Georgievich
- Korobova Svetlana Vjacheslavovna
- Kornilaeva Galina Vladimirovna
- Toporova Viktorija Aleksandrovna
|
RU2577132C1 |
PURIFIED AND ISOLATED NUCLEIC ACID MOLECULE, RECOMBINANT PLASMID, RECOMBINANT VECTOR, PURIFIED AND ISOLATED PROTEIN, PURIFIED AND ISOLATED PROTEIN D15 OR ITS PART OF EXTERNAL ENVELOPE, SYNTHETIC PEPTIDE, CHIMERIC MOLECULE, IMMUNOGENIC COMPOSITION AND ANTISERUM OR ANTIBODY |
1993 |
- Pele Chong
- Vejn Tomas
- Jan-Ping Jang
- Shina Lusmore
- Du Juan Charlz Sia
- Majkl Klejn
|
RU2141528C1 |
OLIGOMERIC PARTICLE INDUCING IMMUNITY AGAINST HEPATITIS C VIRUS, METHOD FOR PREPARING OLIGOMERIC PARTICLE, COMPOSITION, SPECIFIC ANTIBODY, SET (VARIANTS), IMMUNOLOGICAL ANALYSIS AND VACCINE AGAINST HEPATITIS C VIRUS |
1999 |
- Depla Ehrik
- Martens Gert
- Bosman Al'Fons
- Van Vejnendale Frans
|
RU2247729C2 |
MICROFLUIDIZED COMPOSITION FOR INDUCTION OF SPECIFIC CYTOTOXIC T-LYMPHOCYTE IMMUNE RESPONSE AND ITS USING FOR DISEASE TREATMENT |
1995 |
- Rajchaudkhuri Siamal
- Rehstetter Vill'Jam Kh.
|
RU2201253C2 |
ISOLATED POLYPEPTIDES BASED ON NEUTRALISING OF PROTEIN p17 OF HIV VIRUS, USED AS VACCINES, AND NEUTRALISING ANTI-p17-ANTIBODIES, SPECIFICALLY RECOGNISING SAID NEUTRALISING |
2002 |
- Karuzo Arnal'Do
- Frantsone Zhoze Sebast'Jan
|
RU2337922C9 |
METHODS FOR INCREASING VACCINE EFFICIENCY BY INJECTING IL-4R ANTAGONIST |
2017 |
- Purcell Ngambo, Lisa
- Graham, Neil
- Murphy, Andrew J.
- Evans, Robert
|
RU2753869C2 |
METHOD OF ISOLATION AND PURIFICATION OF PROTEIN OF MORAXELLA CATARRHALIS EXTERNAL MEMBRANE, STRAIN MORAXELLA CATARRHALIS FOR PREPARING PROTEIN CD, ISOLATED AND PURIFIED NONDENATURATED PROTEIN CD OF MORAXELLA CATARRHALIS EXTERNAL MEMBRANE AND IMMUNOGENIC COMPOSITION COMPRISING PROTEIN CD OF MORAXELLA CATARRHALIS EXTERNAL MEMBRANE |
1995 |
- Jang Jan-Ping
- Khakness Robin E.
- Majers Liza E.
- Makginness Ursula
- Klejn Majkl Kh.
|
RU2186582C2 |